Corti is a medical software startup that can assist in identifying potential medical conditions, suggest appropriate diagnostic tests, and even propose treatment plans based on historical data and medical guidelines. By analyzing vast amounts of medical data, Corti can identify patterns, trends, and emerging medical knowledge in real time. This ensures that clinicians are always equipped with the latest information and best practices, enhancing their decision-making capabilities.
Corti has raised $60 million in a Series B round. The fresh funding will be used to accelerate healthcare AI innovation and expand work in public safety. Prosus Ventures and Atomico led the new funding round, with previous backers Eurazeo, EIFO, and Chr. Augustinus Fabrikker also participating.
Corti,Copenhagen, Hovedstaden, Denmark, was founded in 2016 by Andreas Cleve Lohmann, Lars Maaløe, and Michael Boesen. “AI is moving faster than ever, and at Corti we continue to stay ahead of the curve by vigilantly competing with big tech on method and application. While lots of companies cannot maintain a competitive edge, the future is bright for the teams that can consistently innovate,” said Lars Maaløe, PhD, Co-Founder & CTO at Corti.
